Equities
Health CareHealth Care Equipment & Services
  • Price (USD)154.77
  • Today's Change-0.24 / -0.15%
  • Shares traded4.06m
  • 1 Year change+37.46%
  • Beta1.0317
Data delayed at least 15 minutes, as of Sep 17 2021 21:10 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Key statistics

On Friday, Quest Diagnostics Inc (DGX:NYQ) closed at 154.77, -3.61% below its 52-week high of 160.56, set on Sep 09, 2021.
52-week range
Today
108.28Sep 25 2020160.56Sep 09 2021
Markit short selling activity
Low
Med
High
Open154.94
High156.83
Low154.61
Bid151.05
Offer163.00
Previous close155.01
Average volume1.47m
Shares outstanding122.18m
Free float113.07m
P/E (TTM)9.22
Market cap18.91bn USD
EPS (TTM)16.78
USD
Annual div (ADY)2.48
USD
Annual div yield (ADY)1.60%
Div ex-dateJul 06 2021
Div pay-dateJul 21 2021
Next div ex-dateOct 04 2021
Next div pay-dateOct 20 2021
Data delayed at least 15 minutes, as of Sep 17 2021 21:10 BST.
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.
image